|OPKO Health, Inc. (OPKO), incorporated in October 1991, is a pharmaceutical and diagnostics company. The Company is focused on developing a range of solutions, including molecular diagnostics tests, pharmaceuticals and vaccines. The Company operates in two segments: pharmaceutical and instrumentation segments. The pharmaceutical segment consists of two operating segments: pharmaceutical research and development segment, which is focused on the research and development of pharmaceutical products, diagnostic tests and vaccines, and the pharmaceutical operations. The instrumentation segment consists of ophthalmic instrumentation devices and the activities related to the research, development, manufacture, and commercialization of those products. On January 31, 2011, OPKO acquired CURNA, Inc., a company engaged in the discovery of new drugs for the treatment of a variety of illnesses, including cancer, heart disease, metabolic disorders and a range of genetic anomalies.